Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ALEXION PHARMACEUTICALS INC Financial Overview

  • Income Statement: ALXN
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 259.10 M 72.04 M 187.06 M 72.20%
    Gross Profit 230.73 M 65.34 M 165.39 M 71.68%
    Net Income Before Extra Items/Preferred Div 33.15 M -92.29 M 125.44 M 378.41%
    Operating Income 34.61 M -99.76 M 134.37 M 388.24%
    View Full Report

  • Cash Flow: ALXN
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 28.31 M 64.84 M -36.54 M -129.07%
    Net Cash Flow - Investing 38.65 M -3.08 M 41.73 M 107.96%
    Net Cash Flow/Operating Activities 53.20 M -139.61 M 192.81 M 362.44%
    View Full Report

  • Balance Sheet: ALXN

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 474.15 M 334.36 M 139.80 M 29.48%
    Total Liabilities 227.15 M 232.80 M -5.65 M -2.49%
    Shareholders Equity 247.00 M 101.56 M 145.44 M 58.88%
    View Full Report

  • Key Ratios / Statistics: ALXN

    • Valuation

      Price/Earnings (TTM) 92.79
      Price/Sales (TTM) 12.57
      Price/Book (MRQ) 9.36
      Price/Cash Flow (TTM) 38.03

    • Profitability

      Gross Margin 89.05
      Operating Margin 13.36
      Profit Margin 12.79

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 2.61
      Current Ratio (MRQ) 3.10
      Long Term Debt-to-Equity (MRQ) 2.32

    • Management Effectiveness

      Return on Equity (TTM) 18.41
      Return on Assets (TTM) 15.06
      Return on Investments (TTM) 10.10
    View All Key Ratios